"Thompson Cancer Survival Center at Methodist offers a high level of cancer care, including state-of-the-art treatments and wellness services designed to care for the whole patient."

During the past decade, Thompson Cancer Survival Center at Methodist conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thompson Cancer Survival Center at Methodist" #1 collaborator was "NRG Oncology" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Thompson Cancer Survival Center at Methodist" are "Adult Giant Cell Glioblastoma" (1 trials), "Adult Glioblastoma" (1 trials), "Adult Gliosarcoma" (1 trials), "Brain and Central Nervous System Tumors" (1 trials) and "Recurrent Adult Brain Neoplasm" (1 trials). Many other conditions were trialed in "Thompson Cancer Survival Center at Methodist" in a lesser frequency.

Most popular intervention types in "Thompson Cancer Survival Center at Methodist" are "Drug" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "100mg/m2 adjuvant temozolomide days 1 to 5 of 28 day cycle" (1 trials), "75mg/m2 adjuvant temozolomide days 1-21 of 28 day cycle" (1 trials), "Concurrent radiation therapy" (1 trials), "Concurrent temozolomide" (1 trials) and "Dasatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thompson Cancer Survival Center at Methodist" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Thompson Cancer Survival Center at Methodist". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Thompson Cancer Survival Center at Methodist, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thompson Cancer Survival Center at Methodist, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".